MARKET

ALEC

ALEC

Alector
NASDAQ
2.300
-0.270
-10.51%
Pre Market: 2.256 -0.044 -1.91% 05:24 11/20 EST
OPEN
2.500
PREV CLOSE
2.570
HIGH
2.590
LOW
2.290
VOLUME
2.11K
TURNOVER
0
52 WEEK HIGH
2.840
52 WEEK LOW
1.090
MARKET CAP
342.42M
P/E (TTM)
6.50
1D
5D
1M
3M
1Y
5Y
1D
Morgan Stanley Reaffirms Their Sell Rating on Alector (ALEC)
TipRanks · 1d ago
Alector Initiated at Overweight by Wells Fargo
Dow Jones · 3d ago
Alector Price Target Announced at $7.00/Share by Wells Fargo
Dow Jones · 3d ago
Weekly Report: what happened at ALEC last week (1109-1113)?
Weekly Report · 4d ago
Alector Holders Are Up 105% And Here Is What They Saw
Simply Wall St · 5d ago
Alector initiated with an Overweight at Wells Fargo
TipRanks · 11/13 10:05
Earnings Estimates Rising for Alector (ALEC): Will It Gain?
NASDAQ · 11/11 16:20
Weekly Report: what happened at ALEC last week (1102-1106)?
Weekly Report · 11/09 09:14
More
About ALEC
Alector, Inc. is a clinical-stage biotechnology company. The Company is focused on developing therapies to counteract the devastating progression of neurodegenerative diseases. It also develops alector brain carrier (ABC), a proprietary blood-brain barrier platform, which is applied to its next-generation product candidates and research pipeline. Its research and drug discovery platform leverages human genetic datasets, advanced tools in bioinformatics and imaging, and insights in neurodegeneration. Its clinical development portfolio includes latozinemab (AL001) and AL101/GSK4527226, while its preclinical and research pipeline candidates include ADP037-ABC, ADP050-ABC, ADP056, and ADP063-ABC/ADP064-ABC. Its first product candidate, latozinemab, is a human recombinant monoclonal antibody that increases the levels of progranulin (PGRN) in the brains of FTD-GRN patients. The AL101/GSK4527226, is a human recombinant monoclonal antibody designed to elevate PGRN levels in the brain.

Webull offers Alector Inc stock information, including NASDAQ: ALEC real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ALEC stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading ALEC stock methods without spending real money on the virtual paper trading platform.